Amarin | Nettoeinkommen





Nettoeinkommen Veränderung Datum
AbbVie USD 1.82B 1.63B 2025-12
Alnylam Pharmaceuticals USD 251.08M 317.36M 2025-09
Amarin USD -7.74M 6.4M 2025-09
AstraZeneca USD 2.33B 207M 2025-12
BioCryst Pharmaceuticals USD -88.88M 74.85M 2024-12
DBV Technologies USD -33.16M 8.71M 2025-09
Esperion Therapeutics USD -29.52M 32.4M 2024-09
GlaxoSmithKline GBP 636M 1.38B 2025-12
Halozyme Therapeutics USD 175.22M 10.06M 2025-09
Heron Therapeutics USD -4.85M 4.39M 2024-09
Ionis Pharmaceuticals USD -128.61M 252.16M 2025-09
Nektar Therapeutics USD -37.06M 15.31M 2024-09
Neurocrine Biosciences USD 209.5M 102M 2025-09
Novartis USD 3.93B 96M 2025-09


Amarin Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.